EU and US team up in the fight against antimicrobial resistanceArchived

ECDC comment

​​The first progress report of the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) was published today. It reviews the implementation of the set of recommendations defined by the TATFAR in 2012, for a better cooperation in the global fight to keep antimicrobials effective. 

​The first progress report of the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) was published today. It reviews the implementation of the set of recommendations defined by the TATFAR in 2012, for a better cooperation in the global fight to keep antimicrobials effective. 

The taskforce focuses on three key areas:

  • appropriate therapeutic use of antimicrobial drugs in medical and veterinary communities;
  • prevention of healthcare- and community-associated drug-resistant infections;
  • strategies for improving the pipeline of new antimicrobial drugs.

ECDC comment: ECDC is a member of the TATFAR as one of the nine representatives of the EU delegation.    ECDC provided the secretariat for the TATFAR from 2009 to 2013. As the concern related to antimicrobial resistance continues to grow, the mandate of the TATFAR has been extended to two additional years (2014 and 2015), during which the US CDC is in charge of the secretariat.